Brainsway Ltd (TA:BWAY) — Market Cap & Net Worth
Market Cap & Net Worth: Brainsway Ltd (BWAY)
Brainsway Ltd (TA:BWAY) has a market capitalization of $442.88 Million (ILA165.19 Billion) as of June 17, 2026. Listed on the TA stock exchange, this Israel-based company holds position #13088 globally and #146 in its home market, demonstrating a 2.36% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Brainsway Ltd's stock price ILA4212.00 by its total outstanding shares 39219973 (39.22 Million). Review how much debt does Brainsway Ltd carry to assess the company's total debt and financial obligations.
Brainsway Ltd Market Cap History: 2015 to 2026
Brainsway Ltd's market capitalization history from 2015 to 2026. Data shows growth from $245.52 Million to $442.88 Million (5.19% CAGR).
Brainsway Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Brainsway Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
4.46x
Brainsway Ltd's market cap is 4.46 times its annual revenue
Latest Price to Earnings (P/E) Ratio
62.67x
Brainsway Ltd's market cap is 62.67 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $245.52 Million | $6.80 Million | -$4.09 Million | 36.11x | N/A |
| 2016 | $169.92 Million | $11.52 Million | -$2.40 Million | 14.74x | N/A |
| 2017 | $176.12 Million | $11.14 Million | -$7.05 Million | 15.80x | N/A |
| 2018 | $225.96 Million | $16.40 Million | -$6.48 Million | 13.78x | N/A |
| 2019 | $176.12 Million | $23.10 Million | -$10.33 Million | 7.62x | N/A |
| 2020 | $119.87 Million | $22.06 Million | -$5.38 Million | 5.43x | N/A |
| 2021 | $126.39 Million | $29.66 Million | -$6.46 Million | 4.26x | N/A |
| 2022 | $37.39 Million | $27.18 Million | -$13.35 Million | 1.38x | N/A |
| 2023 | $120.92 Million | $31.79 Million | -$4.20 Million | 3.80x | N/A |
| 2024 | $183.06 Million | $41.02 Million | $2.92 Million | 4.46x | 62.67x |
Competitor Companies of BWAY by Market Capitalization
Companies near Brainsway Ltd in the global market cap rankings as of June 17, 2026.
Key companies related to Brainsway Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $154.19 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #205 globally with a market cap of $117.85 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #245 globally with a market cap of $103.20 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $154.19 Billion | $88.67 |
| #205 | Stryker Corporation | NYSE:SYK | $117.85 Billion | $307.94 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #245 | Medtronic PLC | NYSE:MDT | $103.20 Billion | $80.38 |
Brainsway Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Brainsway Ltd's market cap moved from $245.52 Million to $ 442.88 Million, with a yearly change of 5.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA442.88 Million | +34.78% |
| 2025 | ILA328.59 Million | +79.49% |
| 2024 | ILA183.06 Million | +51.39% |
| 2023 | ILA120.92 Million | +223.40% |
| 2022 | ILA37.39 Million | -70.42% |
| 2021 | ILA126.39 Million | +5.44% |
| 2020 | ILA119.87 Million | -31.94% |
| 2019 | ILA176.12 Million | -22.06% |
| 2018 | ILA225.96 Million | +28.30% |
| 2017 | ILA176.12 Million | +3.65% |
| 2016 | ILA169.92 Million | -30.79% |
| 2015 | ILA245.52 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Brainsway Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $442.88 Million USD |
| MoneyControl | $442.88 Million USD |
| MarketWatch | $442.88 Million USD |
| marketcap.company | $442.88 Million USD |
| Reuters | $442.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, sc… Read more